Risk of serious conditions reduced regardless of amount of weight lost, say researchers who compare breakthrough to discovery ...
Obesity jabs could cut the risk of heart attacks and strokes in people even if they fail to lose much weight, according to an ...
Novo Nordisk’s weight loss injection semaglutide — the ingredient inside its wildly popular drugs Ozempic and Wegovy — could ...
Those taking the drugs for at least three years cut their risk of heart attack, stroke or cardiac death by 20 per cent ...
Ozempic could dramatically reduce the risk of heart attacks and stroke, a new study indicates. The weight loss jab has become ...
Marketed as Wegovy, Ozempic and Rybelsus, semaglutide injections may benefit obese patients even if they don't lose weight.
A study has found the anti-obesity drug sold under brand names Wegovy, Ozempic and Rybelsus could reduce the risk of heart attacks, strokes ...
New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular ...
A powerful anti-obesity jab has been found to slash the risk of chronic disease regardless of the amount of weight lost.
An obesity drug could cut heart disease and stroke risks even if you don’t lose any weight. New research has shown that ...
Share on Pinterest Researchers say weight-loss medications such as Ozempic can help with heart health as well as long-term ...